• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,645
107
73
69
69

COUNTRY

68
21
17
11
10

CATEGORIES

  • 576
  • 122
  • 558
  • 80
  • 530
  • 43
  • 507
  • 17
  • 19
  • 25

PRICE

813
1,113
1,311
2,779

PUBLISHED

180
274
672
2,779

PRODUCT TYPE

2,204
495
68
7
2
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2014 Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2014 - Product Thumbnail Image

Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2014

Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. However, these three successful drugs are just...

March 2014
Oncology Drug Pathway Analyzer (Premium Version) Oncology Drug Pathway Analyzer (Premium Version) - Product Thumbnail Image

Oncology Drug Pathway Analyzer (Premium Version)

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the...

March 2014
Prostate Cancer Drug Pipeline Update 2014 Prostate Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

Prostate Cancer Drug Pipeline Update 2014

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various...

March 2014
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014 Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014 - Product Thumbnail Image

Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014

Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 231...

March 2014
Brain Cancer Drug Pathway Analyzer 2014 Brain Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Brain Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 213 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways...

March 2014
Gastrointestinal Cancer Drug Pathway Analyzer 2014 Gastrointestinal Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Gastrointestinal Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 185 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways...

March 2014
Ovarian Cancer Drug Pathway Analyzer 2014 Ovarian Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Ovarian Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 320 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways...

March 2014
Pancreatic Cancer Drug Pathway Analyzer 2014 Pancreatic Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Pancreatic Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 294 targeted molecular therapies known to affect more than 246 specific intracellular signaling pathways...

March 2014
Prostate Cancer Drug Pathway Analyzer 2014 Prostate Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Prostate Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 386 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways...

March 2014
Peptides in Oncology: Drug Pathway Analyzer 2014 Peptides in Oncology: Drug Pathway Analyzer 2014 - Product Thumbnail Image

Peptides in Oncology: Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 188 peptide drugs known to affect more than 216 specific intracellular signaling pathways for the treatment...

March 2014
Lung Cancer Drug Pathway Analyzer 2014 Lung Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Lung Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 487 targeted molecular therapies known to affect more than 254 specific intracellular signaling pathways...

March 2014
Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014 Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014 - Product Thumbnail Image

Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 285 nucleic acid drugs known to affect more than 223 specific intracellular signaling pathways for the...

March 2014
Head and Neck Cancer Drug Pathway Analyzer 2014 Head and Neck Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Head and Neck Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 149 targeted molecular therapies known to affect more than 241 specific intracellular signaling pathways...

March 2014
Breast Cancer Drug Pathway Analyzer 2014 Breast Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Breast Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 532 targeted molecular therapies known to affect more than 253 specific intracellular signaling pathways...

March 2014
Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014 Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014 - Product Thumbnail Image

Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 262 conjugated drugs known to affect more than 206 specific intracellular signaling pathways for the...

March 2014
Hematological Cancers Drug Pathway Analyzer 2014 Hematological Cancers Drug Pathway Analyzer 2014 - Product Thumbnail Image

Hematological Cancers Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 672 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways...

March 2014
Colorectal Cancer Drug Pathway Analyzer 2014 Colorectal Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Colorectal Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 375 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways...

March 2014
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014 RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014 - Product Thumbnail Image

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 54 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 157 specific intracellular signaling pathways...

March 2014
Immunotherapy in Oncology: Drug Pathway Analyzer 2014 Immunotherapy in Oncology: Drug Pathway Analyzer 2014 - Product Thumbnail Image

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 811 immunotherapy drugs known to affect more than 234 specific intracellular signaling pathways for...

March 2014
p53 Signaling Pathway in Cancer Drug Pipeline Update 2014 p53 Signaling Pathway in Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

p53 Signaling Pathway in Cancer Drug Pipeline Update 2014

p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes....

March 2014
Loading Indicator

Our Clients

Our clients' logos